Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Pacira Pharm Inc (NQ: PCRX )

17.94 +0.13 (+0.73%)
Streaming Delayed Price Updated: 9:30 AM EST, Dec 3, 2024 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Headline News about Pacira Pharm Inc

< Previous 1 2 3 4 Next >
Investors should take notice of NASDAQ:PCRX—it offers a great deal for the fundamentals it presents.
Despite its impressive fundamentals, PACIRA BIOSCIENCES INC (NASDAQ:PCRX) remains undervalued. 
Via Chartmill
For those who appreciate value investing, NASDAQ:PCRX is a compelling option with its solid fundamentals.
Investors should take notice ofPACIRA BIOSCIENCES INC (NASDAQ:PCRX)—it offers a great deal for the fundamentals it presents. 
Via Chartmill
Earnings Preview: Pacira BioSciences
Via Benzinga
Analyst Expectations for Pacira BioSciences's Future
Via Benzinga
Benzinga's Top Ratings Upgrades, Downgrades For August 3, 2023
Via Benzinga
4 Analysts Have This to Say About Pacira BioSciences
Via Benzinga
Analyst Ratings for Pacira BioSciences
Via Benzinga
Stocks That Hit 52-Week Lows On Tuesday
  On Tuesday, 386 stocks made new 52-week lows. 
Via Benzinga
Looking Into Pacira BioSciences's Return On Capital Employed
Via Benzinga
Stocks That Hit 52-Week Lows On Monday
  Monday's session saw 175 companies set new 52-week lows. 
Via Benzinga
Why Pacira BioSciences Shares Are Trading Lower Today
Pacira BioSciences Inc (NASDAQ: PCRX) reported Q1 sales of $160.3 million compared to $158.0 million a year ago and the  
Via Benzinga
Recap: Pacira BioSciences Q1 Earnings
Via Benzinga
What 6 Analyst Ratings Have To Say About Pacira BioSciences
Via Benzinga
Analyst Expectations for Pacira BioSciences's Future
Via Benzinga
Earnings Preview For Pacira BioSciences
Via Benzinga
Where Pacira BioSciences Stands With Analysts
Via Benzinga
Stocks That Hit 52-Week Lows On Friday
  Friday's session saw 225 companies set new 52-week lows. 
Via Benzinga
Stocks That Hit 52-Week Lows On Monday
  On Monday, 12 stocks hit new 52-week lows. 
Via Benzinga
Pacira BioSciences's Return On Capital Employed Insights
Via Benzinga
Pacira Touts Positive Data From EXPAREL Study In Toe Correction Surgery
Via Benzinga
Pacira Posts Topline Data From Knee Surgery Study With Its Flagship Pain Management Drug
Via Benzinga
Earnings Scheduled For February 28, 2023
Companies Reporting Before The Bell • Gaotu Techedu (NYSE:GOTU) is expected to report earnings for its fourth quarter. 
Via Benzinga
Pacira BioSciences' Return On Capital Employed Overview
  
Via Benzinga
Stocks That Hit 52-Week Lows On Tuesday
  Tuesday's session saw 16 companies set new 52-week lows. 
Via Benzinga
JetBlue Airways, Pacira BioSciences And Some Other Big Stocks Moving Lower On Tuesday
U.S. stocks traded slightly higher, with the Nasdaq Composite gaining around 70 points on Tuesday. Here are some big stocks recording losses in today’s session. 
Via Benzinga
Stocks That Hit 52-Week Lows On Tuesday
  On Tuesday, 49 companies hit new 52-week lows. 
Via Benzinga
Stocks That Hit 52-Week Lows On Wednesday
  On Wednesday, 70 companies set new 52-week lows. 
Via Benzinga
Pacira BioSciences: Q3 Earnings Insights
Pacira BioSciences (NASDAQ:PCRX) reported its Q3 earnings results on Thursday, November 3, 2022 at 08:00 AM. Here's what investors need to know about the announcement. 
Via Benzinga
Pacira Pharmaceuticals Stock Shows Rising Relative Strength
On Friday, Pacira Pharmaceuticals stock got an upgrade to its Relative Strength (RS) Rating, from 69 to 73. 
Via Investor's Business Daily
Important Biotech Catalysts For September 7, 2022 - End Of The Day Summary
Via Benzinga
< Previous 1 2 3 4 Next >
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.